دورية أكاديمية
An Allergic Reaction in Contrast-enhanced Ultrasound Lymphography for Lymphovenous Bypass Surgery
| العنوان: | An Allergic Reaction in Contrast-enhanced Ultrasound Lymphography for Lymphovenous Bypass Surgery |
|---|---|
| المؤلفون: | Jess D. Rames, MD, MEng, Nho V. Tran, MD, Gina K. Hesley, MD, Vahe Fahradyan, MD, Christine U. Lee, MD, PhD |
| المصدر: | Plastic and Reconstructive Surgery, Global Open, Vol 12, Iss 6, p e5908 (2024) |
| بيانات النشر: | Wolters Kluwer, 2024. |
| سنة النشر: | 2024 |
| المجموعة: | LCC:Surgery |
| مصطلحات موضوعية: | Surgery, RD1-811 |
| الوصف: | Summary:. Lymphedema following oncologic intervention can cause significant lifelong morbidity for patients in whom conservative management fails. The associated swelling, discomfort, pain, and recurrent cellulitis greatly diminish quality of life. Surgical procedures, including suction-assisted lipectomy, lymphovenous anastomosis (LVA), and vascularized lymph node transfers, show effectiveness in both volume reduction in affected extremities and symptom relief. However, the success of procedures like LVA is dependent on effective preoperative lymphatic mapping to identify suitable vessels for anastomosis. Traditional superficial lymphatic mapping uses near infrared fluorescence indocyanine green (ICG) imaging. Moreover, recent advances in contrast-enhanced ultrasound (CEUS) lymphography increased lymphovenous bypass target identification for LVA in the extremities.7 CEUS lymphography uses microbubbles as a contrast-enhancing agent injected intradermally into the affected extremity with subsequent identification of superficial collecting lymphatic vessels using ultrasound. Although a recent report noted an uptick in severe and critical adverse drug reactions to an ultrasound contrast agent injected intravenously in stress echocardiography, adverse drug reactions associated with ultrasound contrast-enhancing agents in body ultrasound are rare. The safety profile and potential complications from CEUS lymphography in the lymphedema population have yet to be fully characterized. In this case report, the authors present the first cutaneous adverse drug event following a secondary exposure to the contrast used for CEUS imaging. Mechanisms and justifications for an immune-mediated process are explored, and a review of similar manifestations in other related contrast applications is discussed. |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English |
| تدمد: | 2169-7574 00000000 |
| Relation: | http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000005908; https://doaj.org/toc/2169-7574 |
| DOI: | 10.1097/GOX.0000000000005908 |
| URL الوصول: | https://doaj.org/article/1b8fc8917a0248c699e9358febe22791 |
| رقم الأكسشن: | edsdoj.1b8fc8917a0248c699e9358febe22791 |
| قاعدة البيانات: | Directory of Open Access Journals |
Full Text Finder | تدمد: | 21697574 00000000 |
|---|---|
| DOI: | 10.1097/GOX.0000000000005908 |